| Study name |
Short‐/medium‐/long‐term outcomes |
Group 1 sample size |
Group 2 sample size |
Results Group 1
Mean (standard deviation)
|
Results Group 2
Mean (standard deviation)
|
Other data |
Notes |
| Bernaerts 2020 |
Short‐term oxytocin (24 IU once daily) |
22 |
17 |
1.77 (8.04) |
‐1.35 (6.74) |
‐ |
Skewed |
| Jacob 2022 |
Short‐term balovaptan (10 mg once daily) |
106 |
92 |
8.0 (13.7) |
6.0 (11.6) |
‐ |
Skewed |
|
NCT01908205
(2013) |
Short‐term oxytocin (twice daily dose of max 24 IUs) |
25 |
29 |
14.2 (17.4) |
7.6 (21.3) |
‐ |
Skewed |
|
NCT02940574
(2016) |
Short‐term oxytocin (24 IU once daily) |
22 |
17 |
1.14 (5.48) |
0.35 (4.53) |
‐ |
Skewed |
| Squassante 2018 |
Short‐term balovaptan (1.5 mg) |
26 |
22 |
2.0 (13.7) |
3.9 (13.0) |
‐ |
Skewed |
| Short‐term balovaptan (4 mg) |
69 |
22 |
6.2 (10.8) |
3.9 (13) |
‐ |
| Short‐term balovaptan (10 mg) |
30 |
23 |
9.8 (10.0) |
3.98 (13.0) |
‐ |
